Although b3a2 is the most frequently reported mRNA variant in Mexico [10], studies on the frequency and importance of BCR::ABL1 mRNA variants in patients with CML are still limited. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.